Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Vijan: Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. (0.11 sec) 

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes

- annals.org
S Vijan, TP Hofer, RA Hayward - Annals of internal medicine, 1997 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: The benefits of intensive glycemic control in patients with ...
Cited by 186 - Related articles - BL Direct - All 4 versions

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness …


RC Eastman, JC Javitt, WH Herman, EJ … - Diabetes Care, 1997 - Am Diabetes Assoc
OBJECTIVE: To analyze the health benefits and economics of treating NIDDM with
the goal of normoglycemia. RESEARCH DESIGN AND METHODS: Incidence-based
simulation model of NIDDM was used. Hazard rates for complications were ...
Cited by 301 - Related articles - BL Direct - All 5 versions

Model of complications of NIDDM. I. Model construction and assumptions.


RC Eastman, JC Javitt, WH Herman, EJ … - Diabetes Care, 1997 - Am Diabetes Assoc
OBJECTIVE: To develop a model of NIDDM for analyzing prevention strategies for
NIDDM. RESEARCH DESIGN AND METHODS: A Markov type model with Monte Carlo
techniques was used. Age, sex, and ethnicity of cohort was based on US ...
Cited by 172 - Related articles - BL Direct - All 5 versions

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 …

- rushakoff.com [PDF] 
S Vijan, TP Hofer, RA Hayward - Jama, 2000 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better.
Cited by 155 - Related articles - BL Direct - All 5 versions

Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non …


S Vijan, DM Kent, RA Hayward - Diabetologia, 2000 - Springer
Contrary to the claims of some enthusiasts of evi- dence-based medicine,
randomized clinical trials of- ten provide insufficient evidence to guide
clinical care. Some proponents of ªevidence-basedº medi- cine argue that ...
Cited by 45 - Related articles - BL Direct - All 3 versions

Quality Improvement Initiatives

- diabetesjournals.org
RA Hayward, TP Hofer, EA Kerr, SL Krein - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—The five principles that have guided the QUERI-DM process are: 1)
treating clinical guidelines and goals distinct from quality standards and
quality improvement priorities; 2) targeting high-risk patients and ...
Cited by 35 - Related articles - BL Direct - All 6 versions

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, …

- annals.org
S Vijan, RA Hayward - Annals of internal medicine, 2003 - Am Coll Physicians
Background: Hypertension in patients with type 2 diabetes mellitus is a
prevalent condition that leads to substantial morbidity and mortality. ...
Purpose: To evaluate the goals and optimal agents for treatment of ...
Cited by 186 - Related articles - BL Direct - All 11 versions

[PDF] Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of …


EA Kerr, SL Krein, S Vijan, TP Hofer, RA … - American Journal of Managed Care, 2001 - ajmc.com
Eve A. Kerr, MD, MPH; Sarah L. Krein, PhD, RN; Sandeep Vijan, MD, MS; Timothy P.
Hofer, MD, MS; and Rodney A. Hayward, MD ... Current Efforts to Measure the
Quality of Healthcare In 1997, the President's Advisory Commission on ...
Cited by 91 - Related articles - View as HTML - BL Direct - All 3 versions

Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and …


MM Engelgau, RE Aubert, TJ Thompson, WH … - Diabetes Care, 1995 - Am Diabetes Assoc
The economic burden of diabetes in the US is now more than 90 billion dollars
per year (113-115). In the diabetes community, there is a feeling that
aggressive measures to detect diabetes in earlier stages may be warranted. ...
Cited by 70 - Related articles - BL Direct - All 6 versions

Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and …


RA Hayward, WG Manning, SH Kaplan, EH … - Jama, 1997 - Am Med Assoc
CONTEXT: Although experimental studies show that insulin therapy can be safe and
efficacious in improving glycemic control in type 2 diabetes under optimal
conditions (ie, using patient volunteers with close monitoring under strict ...
Cited by 186 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google